Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 31, 2012
Patent Application Number
12503175
Date Filed
July 15, 2009
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to antibodies that specifically bind to the BAFF receptor (BAFFR). The invention more specifically relates to specific antibodies that are BAFFR antagonists with in vivo B cell depleting activity and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by killing or depleting B cells, such as systemic lupus erythematosus or rheumatoid arthritis or other autoimmune diseases or lymphomas, leukemias and myelomas.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
